Apyx Medical Corp

BOV

Company Profile

  • Business description

    Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

  • Contact

    5115 Ulmerton Road
    ClearwaterFL33760
    USA

    T: +1 727 384-2323

    E: [email protected]

    https://apyxmedical.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    220

Stocks News & Analysis

stocks

ASX healthcare giant remains well positioned despite share slump

We welcome the CEO change at CSL but relatively soft plasma performance will postpone recovery
stocks

Australian bank remains overvalued despite strong result

When strong fundamentals meet persistent valuation headwinds.
stocks

Chart of the Week: Soft earnings growth outlook for Australian banks

The latest take from our equity research analysts.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,281.8041.30-0.44%
CAC 408,403.8990.651.09%
DAX 4025,157.55301.401.21%
Dow JONES (US)49,640.92480.48-0.96%
FTSE 10010,463.009.11-0.09%
HKSE27,032.54233.84-0.86%
NASDAQ22,681.30385.16-1.67%
Nikkei 22557,639.8410.70-0.02%
NZX 50 Index13,531.4824.200.18%
S&P 5006,862.4279.05-1.14%
S&P/ASX 2009,043.5018.50-0.20%
SSE Composite Index4,134.022.030.05%

Market Movers